Jones J C, Balkcom I L, Worman R K
Postgrad Med. 1987 Jul;82(1):244-9. doi: 10.1080/00325481.1987.11699912.
Treatment of effort-induced subclavian-axillary vein thrombosis of the upper extremity is aimed at elimination of the chronic symptoms of the postphlebitic syndrome. Various treatments have been tried, with varied success. Recently, fibrinolytic therapy with streptokinase (Abbokinase) or urokinase (Kabikinase, Streptase) has gained popularity as a treatment option. In the case presented here, complete lysis of effort-induced subclavian-axillary vein thrombosis was achieved with the use of catheter-directed infusion of streptokinase. Subsequently, a pulmonary embolus developed, causing marked morbidity. It is likely that fibrinolytic therapy was directly responsible for this complication. The current literature does not support routine use of fibrinolytic agents in the treatment of effort-induced thrombi of the upper extremity, since these agents can cause significant morbidity. We conclude that fibrinolytic therapy should be reserved for life-threatening conditions, such as myocardial infarction, massive pulmonary emboli, and significant arterial occlusions.
上肢劳力性锁骨下-腋静脉血栓形成的治疗旨在消除血栓形成后综合征的慢性症状。人们尝试了各种治疗方法,效果各异。近来,使用链激酶(Abbokinase)或尿激酶(Kabikinase、Streptase)进行纤维蛋白溶解疗法已成为一种受欢迎的治疗选择。在本文介绍的病例中,通过导管定向注入链激酶实现了劳力性锁骨下-腋静脉血栓形成的完全溶解。随后,发生了肺栓塞,导致明显的发病情况。很可能纤维蛋白溶解疗法直接导致了这一并发症。目前的文献不支持在上肢劳力性血栓形成的治疗中常规使用纤维蛋白溶解剂,因为这些药物可导致明显的发病情况。我们得出结论,纤维蛋白溶解疗法应仅用于危及生命的情况,如心肌梗死、大面积肺栓塞和严重动脉闭塞。